266 related articles for article (PubMed ID: 30916803)
1. MYH9-related disease mutations cause abnormal red blood cell morphology through increased myosin-actin binding at the membrane.
Smith AS; Pal K; Nowak RB; Demenko A; Zaninetti C; Da Costa L; Favier R; Pecci A; Fowler VM
Am J Hematol; 2019 Jun; 94(6):667-677. PubMed ID: 30916803
[TBL] [Abstract][Full Text] [Related]
2. Myosin IIA interacts with the spectrin-actin membrane skeleton to control red blood cell membrane curvature and deformability.
Smith AS; Nowak RB; Zhou S; Giannetto M; Gokhin DS; Papoin J; Ghiran IC; Blanc L; Wan J; Fowler VM
Proc Natl Acad Sci U S A; 2018 May; 115(19):E4377-E4385. PubMed ID: 29610350
[TBL] [Abstract][Full Text] [Related]
3. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.
Pal K; Nowak R; Billington N; Liu R; Ghosh A; Sellers JR; Fowler VM
Blood; 2020 May; 135(21):1887-1898. PubMed ID: 32315395
[TBL] [Abstract][Full Text] [Related]
4. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
[TBL] [Abstract][Full Text] [Related]
5. Linking the Landscape of
Asensio-Juárez G; Llorente-González C; Vicente-Manzanares M
Cells; 2020 Jun; 9(6):. PubMed ID: 32545517
[TBL] [Abstract][Full Text] [Related]
6. MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.
Zaninetti C; De Rocco D; Giangregorio T; Bozzi V; Demeter J; Leoni P; Noris P; Ryhänen S; Barozzi S; Pecci A; Savoia A
Hamostaseologie; 2019 Feb; 39(1):87-94. PubMed ID: 29996171
[TBL] [Abstract][Full Text] [Related]
7. Myosin IIA is critical for organelle distribution and F-actin organization in megakaryocytes and platelets.
Pertuy F; Eckly A; Weber J; Proamer F; Rinckel JY; Lanza F; Gachet C; Léon C
Blood; 2014 Feb; 123(8):1261-9. PubMed ID: 24243973
[TBL] [Abstract][Full Text] [Related]
8. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
Pecci A; Panza E; Pujol-Moix N; Klersy C; Di Bari F; Bozzi V; Gresele P; Lethagen S; Fabris F; Dufour C; Granata A; Doubek M; Pecoraro C; Koivisto PA; Heller PG; Iolascon A; Alvisi P; Schwabe D; De Candia E; Rocca B; Russo U; Ramenghi U; Noris P; Seri M; Balduini CL; Savoia A
Hum Mutat; 2008 Mar; 29(3):409-17. PubMed ID: 18059020
[TBL] [Abstract][Full Text] [Related]
9. MYH9 gene mutations associated with bleeding.
Savoia A; De Rocco D; Pecci A
Platelets; 2017 May; 28(3):312-315. PubMed ID: 28368695
[No Abstract] [Full Text] [Related]
10. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.
Pecci A; Klersy C; Gresele P; Lee KJ; De Rocco D; Bozzi V; Russo G; Heller PG; Loffredo G; Ballmaier M; Fabris F; Beggiato E; Kahr WH; Pujol-Moix N; Platokouki H; Van Geet C; Noris P; Yerram P; Hermans C; Gerber B; Economou M; De Groot M; Zieger B; De Candia E; Fraticelli V; Kersseboom R; Piccoli GB; Zimmermann S; Fierro T; Glembotsky AC; Vianello F; Zaninetti C; Nicchia E; Güthner C; Baronci C; Seri M; Knight PJ; Balduini CL; Savoia A
Hum Mutat; 2014 Feb; 35(2):236-47. PubMed ID: 24186861
[TBL] [Abstract][Full Text] [Related]
11. MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.
Pecci A; Ma X; Savoia A; Adelstein RS
Gene; 2018 Jul; 664():152-167. PubMed ID: 29679756
[TBL] [Abstract][Full Text] [Related]
12. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
[TBL] [Abstract][Full Text] [Related]
13. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease.
Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG
Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509
[TBL] [Abstract][Full Text] [Related]
14. A De Novo Mutation in MYH9 in a Child With Severe and Prolonged Macrothrombocytopenia.
Li K; Jin R; Xu W; Shen Y; Lu K; Wu X
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e7-e10. PubMed ID: 32520844
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of
Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
[No Abstract] [Full Text] [Related]
16. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
[TBL] [Abstract][Full Text] [Related]
17. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.
Arif AR; Zhao M; Chen W; Xue M; Luo S; Wang Y
Platelets; 2022 Nov; 33(8):1307-1311. PubMed ID: 35791514
[TBL] [Abstract][Full Text] [Related]
18. Role for formin-like 1-dependent acto-myosin assembly in lipid droplet dynamics and lipid storage.
Pfisterer SG; Gateva G; Horvath P; Pirhonen J; Salo VT; Karhinen L; Varjosalo M; Ryhänen SJ; Lappalainen P; Ikonen E
Nat Commun; 2017 Mar; 8():14858. PubMed ID: 28361956
[TBL] [Abstract][Full Text] [Related]
19. MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations.
De Rocco D; Zieger B; Platokouki H; Heller PG; Pastore A; Bottega R; Noris P; Barozzi S; Glembotsky AC; Pergantou H; Balduini CL; Savoia A; Pecci A
Eur J Med Genet; 2013 Jan; 56(1):7-12. PubMed ID: 23123319
[TBL] [Abstract][Full Text] [Related]
20. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder.
Wasano K; Matsunaga T; Ogawa K; Kunishima S
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3547-3552. PubMed ID: 26942920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
